RALLIS CHRIS A sold 11.7% of their position (8.35K shares) of FENNEC PHARMACEUTICALS INC. on the open market
Open‑market sale worth $58.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/12/2026ACC: 0001185945-26-000002
Director
Since Jun 2019
-8.35K
Net shares
Net seller
$58.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
14.34K acquired · 22.69K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+14.34K
Price / share
$2.44
Trade value
$35K
% of position
25.1%
5/11/2026
57.08K→71.42K
Common Shares
Direct
Shares
−8.35K
Price / share
$7.04
Trade value
$58.76K
% of position
11.7%
5/11/2026
71.42K→63.08K
Total
Net shares
+6K
Net value
-$23.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 5/11/2026 | M · Option Exercise | +14.34K | $2.44 | $35K | 25.1% | 57.08K | 71.42K |
| Common Shares Direct | 5/11/2026 | S · Sale | −8.35K | $7.04 | $58.76K | 11.7% | 71.42K | 63.08K |
| Total | +6K | -$23.76K | ||||||
Derivative Transactions1
Stock Option
Direct
Converts to
Common shares
14.34K shares
Shares
−14.34K
Strike price
2.44
Held after
186.19K
Exercisable
—
5/11/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common shares14.34K shares | 5/11/2026 | M · Option Exercise | −14.34K | 2.44 | — | 186.19K |